Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-850-4 | CAS number: 84434-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Reactive Blue 198 is practically non-toxic. The LD50 for oral administration is > 2000 mg/kg body weight, the LD50 for dermal application with the structural analogue 01 lies above 2000 mg/kg body weight.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Remarks:
- for studies; but report not inspected
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 females
5 males - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observation: clinical signs multiple times on day one, thereafter twice daily; body weight: weekly
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animals died at 2000 mg/kg
- Clinical signs:
- other: No significant signs of systemic toxicity observed.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral lethal dose was tested to be > 2000 mg/kg bw in both male and female rats.
- Executive summary:
The test substance was tested for acute oral toxicity in 5 female and 5 female rats per dose group. The test substance was administered as a single dose of 2000 mg/kg bw by gavage after a 16-hour fasting period. The animals were observed for 14 days for signs of toxicity and body weight development.
Surviving rats at the end of the observation period underwent necropsy and macroscopical evaluation.The LD50 was determined to be > 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1994
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Barriered Animal Breeding Unit, Zeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK
- Age at study initiation: young adults
- Weight at study initiation: males 265-328g; females 167-188g
- Housing: single
- Diet: Porton Combined Diet
- Water: automatic supply of water ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 23°C
- Humidity (%): 40 to 70
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 28. April 1994 To: 13. May 1994 - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- The substance was tested as a paste with deionised water.
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing:
- Clinical signs: once daily
- Body weight: on day 1, 3, 6, 8 and 15
- Necropsy of survivors performed: yes
Sixteen to thirty-two hours before application of the test sample, the hair was removed with a pair of veterinary clippers from an area, approximately 10cmx 5cm , on the dorso-lumbar region of each animal.
A dose-level of 2000mg/kg was selected.
The appropriate amount was calculated for each animal according to its weight at the time of dosing. The paste, covered by a gauze patch (approximately 4cm x 6cm x 4-ply) was applied to the shorn back of each animal and was kept in contact with the skin for 24 hours using an occlusive dressing. The gauze patch was covered by a patch of plastic film (7.5cm x 5cm) and was held jn position using adhesive bandage (25cm x 5cm). This was secured by twop~ece~ of PVC tape (approximately 2.5cm x 20cm) wrapped around the animal.
At the end of the 24-hour contact period, the dressings were carefully cut, using blunt-tipped scissors, removed and discarded. The skin, at the site
of application, was cleansed free of any residual test sample using clean swabs of absorbent cotton wool soaked in clean warm water and was then
dried gently with clean tissue paper.
The animals were observed for signs of systemic toxicity once between one and four hours after application (only gross abnormalities were noted at
this time as the presence of the dressings may have affected the behaviour and movement of the rats) and then once daily for systemic toxicity and
skin irritation, up to day 15. The animals were weighed immediately before application of the test sample (day I), and at intervals thereafter. At the end of the study, all of the animals were humanely killed by inhalation of halothane vapour followed bJ exsanguination and were subjected to a post mortem examination. - Statistics:
- mean and standard deviation of body weight data
- Preliminary study:
- Not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured.
- Clinical signs:
- other: None of the animals died. The test sample stained the skin of the application sites of all animals blue which, in some cases, was still present at the end of the study (day 15). The tails of some animals were stained blue. Signs of slight skin irritation
- Gross pathology:
- The only findings at the post mortem examination were blue staining by the test substance and scabbing of the skin at the application site. There
were no other findings. - Other findings:
- None
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results obtained in this study, the dermal median lethal dose value (LD50) for the male and female rat is greater than 2000 mg/kg bw.
- Executive summary:
Acute dermal toxicity testing of structural analogue 01 in the rat yielded a dermal median lethal dose (LD50) above 2000 mg/kg bw in both male and female rats. After administration of 2000 mg/kg bw neither deaths nor clinical signs occurred. Only the surface of the skin was blue discolored to a smaller or larger extend. Development of body weight was not impaired. The animals killed at the end of the observation period showed no macroscopically visible changes.
Based on the results obtained in this study, the dermal median lethal dose value (LD50) for the male and female rat is greater than 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
The acute oral toxicity of Reactive Blue 198 in the male and female Wistar rat was determined to be > 2000 mg/kg body weight.
The Structural Analogue 01was examined for acute dermal toxicity in Wistar rat male and female a lethal dose media (LD50) of > 2000 mg / kg body weight. After administration of 2000 mg / kg bw no deaths or related symptoms were observed.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.